• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美西律对钠通道的阻滞作用在长QT综合征的LQT2和LQT3模型中,能有效减少复极离散并预防尖端扭转型室性心动过速。

Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.

作者信息

Shimizu W, Antzelevitch C

机构信息

Masonic Medical Research Laboratory, Utica, NY 13501-1787, USA.

出版信息

Circulation. 1997 Sep 16;96(6):2038-47. doi: 10.1161/01.cir.96.6.2038.

DOI:10.1161/01.cir.96.6.2038
PMID:9323097
Abstract

BACKGROUND

This study examines the contribution of transmural heterogeneity of transmembrane activity to phenotypic T-wave patterns and the effects of pacing and of sodium channel block under conditions mimicking HERG and SCN5A defects linked to the congenital long-QT syndrome (LQTS).

METHODS AND RESULTS

A transmural ECG and transmembrane action potentials from epicardial, M, and endocardial or Purkinje cells were simultaneously recorded in an arterially perfused wedge of canine left ventricle. d-Sotalol was used to mimic LQT2, whereas ATX-II mimicked LQT3. d-Sotalol caused a preferential prolongation of the M cell action potential duration (APD90, 291+/-14 to 354+/-35 ms), giving rise to broad and sometimes low-amplitude bifurcated T waves and an increased transmural dispersion of repolarization (TDR, 51+/-15 to 72+/-17 ms). QT interval increased from 320+/-13 to 385+/-37 ms. ATX-II produced a preferential prolongation of the M cell APD90 (280+/-25 to 609+/-49 ms) and caused a marked delay in the onset of the T wave and a sharp rise in TDR (40+/-5 to 168+/-40 ms). QT-, APD90-, and dispersion-rate relations were much steeper in the ATX-II than in the d-sotalol model. Mexiletine (2 to 20 micromol/L) dose-dependently abbreviated the QT interval and APD90 of all cell types, more in the ATX-II than in the d-sotalol model, but decreased TDR equally in the two models. Mexiletine 2 to 5 micromol/L totally suppressed spontaneous torsade de pointes (TdP) and reduced the vulnerable window during which single extrastimuli could induce TdP in both models. Higher concentrations of mexiletine (10 to 20 micromol/L) totally suppressed stimulation-induced TdP.

CONCLUSIONS

Our results suggest that although pacing and sodium channel block are very effective in abbreviating the QT interval and TDR in LQT3, these therapeutic approaches may also be valuable in reducing the incidence of arrhythmogenesis in LQT2.

摘要

背景

本研究在模拟与先天性长QT综合征(LQTS)相关的HERG和SCN5A缺陷的条件下,探讨跨膜活性的跨壁异质性对T波表型模式的影响以及起搏和钠通道阻滞的作用。

方法与结果

在犬左心室动脉灌注楔形组织中同时记录跨壁心电图和心外膜、M细胞以及心内膜或浦肯野细胞的跨膜动作电位。用d - 索他洛尔模拟LQT2,而用ATX - II模拟LQT3。d - 索他洛尔优先延长M细胞动作电位时程(APD90,从291±14毫秒延长至354±35毫秒),导致T波宽大,有时振幅较低且呈双峰,复极跨壁离散度增加(TDR,从51±15毫秒增加至72±17毫秒)。QT间期从320±13毫秒增加至385±37毫秒。ATX - II优先延长M细胞APD90(从280±25毫秒延长至609±49毫秒),导致T波起始明显延迟且TDR急剧升高(从40±5毫秒升高至168±40毫秒)。在ATX - II模型中,QT、APD90和离散度 - 速率关系比在d - 索他洛尔模型中陡峭得多。美西律(2至20微摩尔/升)剂量依赖性地缩短所有细胞类型的QT间期和APD90,在ATX - II模型中的作用比在d - 索他洛尔模型中更明显,但在两个模型中均同等程度地降低TDR。2至5微摩尔/升的美西律完全抑制了两个模型中的自发性尖端扭转型室速(TdP),并缩小了单个期外刺激可诱发TdP的易损窗口。更高浓度的美西律(10至20微摩尔/升)完全抑制了刺激诱发的TdP。

结论

我们的结果表明,尽管起搏和钠通道阻滞在缩短LQT3的QT间期和TDR方面非常有效,但这些治疗方法在降低LQT2心律失常的发生率方面可能也有价值。

相似文献

1
Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.美西律对钠通道的阻滞作用在长QT综合征的LQT2和LQT3模型中,能有效减少复极离散并预防尖端扭转型室性心动过速。
Circulation. 1997 Sep 16;96(6):2038-47. doi: 10.1161/01.cir.96.6.2038.
2
Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.美西律阻断钠通道对逆转长QT综合征体外模型中动作电位延长的作用。
J Cardiovasc Electrophysiol. 1997 Nov;8(11):1280-90. doi: 10.1111/j.1540-8167.1997.tb01019.x.
3
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.钾通道开放剂对减少复极跨壁离散度及预防长QT综合征LQT1、LQT2和LQT3模型中尖端扭转型室速的作用。
Circulation. 2000 Aug 8;102(6):706-12. doi: 10.1161/01.cir.102.6.706.
4
Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.长QT综合征中长QT间期、复极跨壁离散度及尖端扭转型室速的细胞基础
J Electrocardiol. 1999;32 Suppl:177-84. doi: 10.1016/s0022-0736(99)90077-8.
5
Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.在获得性和先天性长QT综合征模型中,戊巴比妥钠可减少复极的跨壁离散,并预防尖端扭转型室速。
J Cardiovasc Electrophysiol. 1999 Feb;10(2):154-64. doi: 10.1111/j.1540-8167.1999.tb00656.x.
6
Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.长QT综合征LQT1型心电图特征的细胞基础:β-肾上腺素能激动剂、拮抗剂及钠通道阻滞剂对复极跨壁离散度及尖端扭转型室速的影响
Circulation. 1998 Nov 24;98(21):2314-22. doi: 10.1161/01.cir.98.21.2314.
7
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.β-肾上腺素能激动剂和拮抗剂在长QT综合征的LQT1、LQT2和LQT3模型中的差异效应。
J Am Coll Cardiol. 2000 Mar 1;35(3):778-86. doi: 10.1016/s0735-1097(99)00582-3.
8
Molecular biology of the long QT syndrome: impact on management.长QT综合征的分子生物学:对治疗的影响。
Pacing Clin Electrophysiol. 1997 Aug;20(8 Pt 2):2052-7. doi: 10.1111/j.1540-8159.1997.tb03626.x.
9
Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall.2期早期后除极作为获得性长QT综合征多形性室性心动过速的触发因素:来自完整左心室壁细胞内记录的直接证据
Circulation. 2001 Jun 12;103(23):2851-6. doi: 10.1161/01.cir.103.23.2851.
10
Cellular and ionic basis for T-wave alternans under long-QT conditions.长QT间期条件下T波交替的细胞和离子基础。
Circulation. 1999 Mar 23;99(11):1499-507. doi: 10.1161/01.cir.99.11.1499.

引用本文的文献

1
Current and future precision therapy approaches in the long QT syndrome.长QT综合征当前及未来的精准治疗方法
Med Genet. 2025 Jul 17;37(3):189-196. doi: 10.1515/medgen-2025-2015. eCollection 2025 Jul.
2
Clinical, Electrical, and Mechanical Parameters in Potassium Channel-Mediated Congenital Long QT Syndrome.钾通道介导的先天性长QT综合征的临床、电学和力学参数
J Clin Med. 2025 Apr 8;14(8):2540. doi: 10.3390/jcm14082540.
3
Electrocardiographic Discrimination of Long QT Syndrome Genotypes: A Comparative Analysis and Machine Learning Approach.
长QT综合征基因型的心电图鉴别:比较分析与机器学习方法
Sensors (Basel). 2025 Apr 2;25(7):2253. doi: 10.3390/s25072253.
4
Origin of ventricular fibrillation triggers in a model of localized repolarization heterogeneity.局部复极异质性模型中心室颤动触发因素的起源
Heart Rhythm. 2025 May;22(5):1345-1354. doi: 10.1016/j.hrthm.2024.10.027. Epub 2024 Oct 21.
5
Recent Advances in Inherited Cardiac Arrhythmias and Their Genetic Testing.遗传性心律失常及其基因检测的最新进展
Cureus. 2023 Oct 25;15(10):e47653. doi: 10.7759/cureus.47653. eCollection 2023 Oct.
6
Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.慢性美西律治疗 SCN5A 重叠综合征患者的有益作用。
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad154.
7
Characterization of the electrocardiogram of microminipig in comparison with that of Clawn miniature swine: impacts of miniaturization of body size on electrocardiographic indices.微型猪与克劳恩小型猪心电图特征比较:体尺小型化对心电图指标的影响。
J Vet Med Sci. 2023 Aug 1;85(8):828-831. doi: 10.1292/jvms.23-0049. Epub 2023 Jun 9.
8
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2.血清/糖皮质激素调节激酶 1 抑制在 1 型和 2 型长 QT 综合征中的基因和变异体特异性疗效。
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad094.
9
A case of long QT syndrome type 2 that developed torsades de pointes two days after the initiation of oral β-blocker therapy.1例2型长QT综合征患者在开始口服β受体阻滞剂治疗两天后发生尖端扭转型室速。
HeartRhythm Case Rep. 2022 Aug 9;8(11):739-744. doi: 10.1016/j.hrcr.2022.08.003. eCollection 2022 Nov.
10
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2020年心律失常药物治疗指南》
J Arrhythm. 2022 Oct 25;38(6):833-973. doi: 10.1002/joa3.12714. eCollection 2022 Dec.